(Ala¹¹·²²·²⁸)-VIP (human, mouse, rat)
€ 205.40 – € 370.20
Pack size available | 0.5mg, 1mg |
---|
Please select pack size:
Product Description
Highly selective human VPAC1 receptor agonist. It showed a 1000-fold higher efficiency in stimulating adenylate cyclase activity from VPAC1 than from VPAC2 receptors and therefore represents an effective pharmacological tool to characterize VPAC1 receptor-mediated events.